Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) (EMINENCE)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Momenta Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00543400
First received: October 11, 2007
Last updated: April 30, 2013
Last verified: April 2013